COLUMBUS, Ohio — Scientists at The Ohio State University Wexner Medical Center and College of Medicine have discovered a new variant of SARS-Cov-2, the virus that causes COVID-19, officials announced early Wednesday morning.
“The new variant carries a mutation identical to the U.K. strain, but it likely arose in a virus strain already present in the United States,” officials noted in a press release. “The researchers also report the evolution of another U.S. strain that acquired three other gene mutations not previously seen together in SARS-Cov-2.”
Health officials say the new variant was found in a patient from Ohio, but researchers do not yet know the prevalence of the strain within the population. In contrast, officials say, the evolving strain with the three new mutations has become the dominant virus in Columbus during a three-week period in late December 2020 and January.
“This new Columbus strain has the same genetic backbone as earlier cases we’ve studied, but these three mutations represent a significant evolution,” said study leader Dr. Dan Jones, vice chair of the division of molecular pathology. “We know this shift didn’t come from the U.K. or South African branches of the virus.”
SUBSCRIBE: Get the day's top headlines sent to your inbox each weekday morning with the free 3News to GO! newsletter
Like the U.K. strain, mutations detected in both viruses affect the spikes that stud the surface of SARS-Cov-2. The spikes enable the virus to attach to and enter human cells. Also like the U.K. strain, officials say the mutations in the Columbus strain are likely to make the virus more infectious, making it easier for the virus to pass from person to person.
“The big question is whether these mutations will render vaccines and current therapeutic approaches less effective,” said Peter Mohler, a co-author of the study and chief scientific officer at the Ohio State Wexner Medical Center and vice dean for research at the College of Medicine. “At this point, we have no data to believe that these mutations will have any impact on the effectiveness of vaccines now in use.”
Mohler stressed it’s important not to overreact to the new variant until additional data is obtained.
“We need to understand the impact of mutations on transmission of the virus, the prevalence of the strain in the population and whether it has a more significant impact on human health. Further, it is critical that we continue to monitor the evolution of the virus so we can understand the impact of the mutant forms on the design of both diagnostics and therapeutics. It is critical that we make decisions based on the best science.”
The scientists said that discovery of the Columbus variant, COH.20G/501Y, suggests that the same mutation may be occurring independently in multiple parts of the world during the past few months.
“Viruses naturally mutate and evolve over time, but the changes seen in the last two months have been more prominent than in the first months of the pandemic,” Jones said. His team has been conducting Ohio State’s genetic sequencing on environmental and patient SARS-CoV2 samples, and he’ll continue to monitor for changes as vaccination occurs.